Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TET2 | Q6N021 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28895183 | 0.81 | RAB9A (0.34) | TET2 | |
| SCHEMBL23637603 | 0.74 | GAA (0.35) | — | |
| SCHEMBL5673103 | 0.72 | — | — | |
| SCHEMBL1767666 | 0.72 | — | — | |
| SCHEMBL7936208 | 0.70 | — | — | |
| SCHEMBL9359207 | 0.70 | — | — | |
| SCHEMBL10910411 | 0.70 | TDP1 (0.35) | — | |
| SCHEMBL29573839 | 0.70 | MEN1 (0.39) | — | |
| SCHEMBL21716651 | 0.69 | ALDH1A1 (0.41) | — | |
| SCHEMBL8855259 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6359006-B2 | ANTIISCHEMIC AGENTS; ANTICANCER AGENTS | ALLIANCE PHARMACEUTICAL CORP. | 2002-03-19 | — | — | US | disclosed |
| US-20020019442-A1 | AMPHIPHILIC FLUORINE DERIVATIVES WITH TELOMERIC STRUCTURES; PREPARATION PROCEDURE AND BIOMEDICAL APPLICATIONS | PFC THERAPEUTICS, LLC | 2002-02-14 | — | — | US | disclosed |
| US-5847206-A | Amphiphilic fluorine derivatives with telomeric structures; preparation procedure and biomedical applications | ALLIANCE PHARMACEUTICAL CORP. (US) | 1998-12-08 | — | — | US | disclosed |
| US-5703126-A | USED AS MARKER, CARRIERS IN TRANSPORT OF GASES, CONTRAST AGENT, DRUG OR CARRIER FOR DRUG | ALLIANCE PHARMACEUTICAL CORP. (US) | 1997-12-30 | — | — | US | disclosed |
| US-5527962-A | FLUOROPOLYMER WITH PERFLUOROALKYL MERCAPTAN END GROUP AS CARRIER FOR DRUG DELIVERY | ALLIANCE PHARMACEUTICAL CORP. (US) | 1996-06-18 | — | — | US | disclosed |
| EP-0548096-B1 | AMPHIPHILIC FLUORINE DERIVATIVES WITH TELOMERIC STRUCTURES; PREPARATION AND BIOMEDICAL APPLICATIONS | ATTA (FR) | 1995-11-08 | — | — | EP | disclosed |
| EP-0548096-A1 | AMPHIPHILIC FLUORINE DERIVATIVES WITH TELOMERIC STRUCTURES; PREPARATION AND BIOMEDICAL APPLICATIONS. | ATTA (FR) | 1993-06-30 | — | — | EP | disclosed |
| WO-1992002560-A1 | AMPHIPHILIC FLUORINE DERIVATIVES WITH TELOMERIC STRUCTURES; PREPARATION AND BIOMEDICAL APPLICATIONS | S.A. A.T.T.A. APPLICATIONS ET TRANSFERTS DE TECHNO (FR) | 1992-02-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020019442-A1 | AMPHIPHILIC FLUORINE DERIVATIVES WITH TELOMERIC STRUCTURES; PREPARATION PROCEDURE AND BIOMEDICAL APPLICATIONS | POT1, TERF2, TELO2 | TET2 1142/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.